BioStem Technologies (BSEM) Earnings Date, Estimates & Call Transcripts $10.05 -0.30 (-2.90%) As of 08/11/2025 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock BioStem Technologies Earnings Summary BioStem Technologies posted Q4 2024 earnings on May 12, 2025, reporting an EPS of $0.17, which missed the consensus estimate of $1.25 by $1.08. Quarterly revenue was reported to be $72.53 million, below the consensus estimate of $101.20 million. With a trailing EPS of $1.47 and a P/E Ratio of 6.84, BioStem Technologies' earnings are expected to grow 62.41% next year, from $1.41 to $2.29 per share. Upcoming Earnings DateAug. 14After Market ClosesEstimatedConsensus EPS (May. 12) $1.25 Actual EPS (May. 12) $0.17 Missed By -$1.08 Actual Revenue (May. 12) $72.53MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K)BSEM Upcoming EarningsBioStem Technologies' Q2 2025 earnings is scheduled for Thursday, August 14, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get BioStem Technologies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioStem Technologies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBSEM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BSEM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BioStem Technologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.79$0.79$0.79Q2 20251$0.22$0.22$0.22Q3 20251$0.18$0.18$0.18Q4 20251$0.19$0.19$0.19 FY 2025 4 $1.38 $1.38 $1.38 Q1 20261$0.52$0.52$0.52Q2 20261$0.57$0.57$0.57Q3 20261$0.61$0.61$0.61 BioStem Technologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)-------5/12/2025Q4 2024$1.25$0.17 -$1.08$0.17$101.20M$72.53M11/12/2024-$0.31$0.32+$0.01$0.32$78.22M$82.56M8/12/2024Q2 2024$0.12$0.30+$0.18$0.30$43.99M$74.49M5/14/2024Q1 2024$0.74$0.20 -$0.54$0.20$12.70M$41.90M4/1/2024Q4 2023--$0.14--$0.14$11.40M$11.44M11/13/2023Q3 2023-$0.18$0.03+$0.21$0.03$1.39M$3.60M BioStem Technologies Earnings - Frequently Asked Questions When is BioStem Technologies' earnings date? BioStem Technologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on BSEM's earnings history. Did BioStem Technologies beat their earnings estimates last quarter? In the previous quarter, BioStem Technologies (OTCMKTS:BSEM) missed the analysts' consensus estimate of $1.25 by $1.08 with a reported earnings per share (EPS) of $0.17. Learn more on analysts' earnings estimate vs. BSEM's actual earnings. How can I listen to BioStem Technologies' earnings conference call? The conference call for BioStem Technologies' latest earnings report can be listened to online. Listen to Conference Call How can I read BioStem Technologies' conference call transcript? The conference call transcript for BioStem Technologies' latest earnings report can be read online. Read Transcript How much revenue does BioStem Technologies generate each year? BioStem Technologies (OTCMKTS:BSEM) has a recorded annual revenue of $301.83 million. What is BioStem Technologies' price-to-earnings ratio? BioStem Technologies (OTCMKTS:BSEM) has a trailing price-to-earnings ratio of 6.84 and a forward price-to-earnings ratio of 7.13. What is BioStem Technologies' EPS forecast for next year? BioStem Technologies' earnings are expected to grow from $1.41 per share to $2.29 per share in the next year, which is a 62.41% increase. More Earnings Resources from MarketBeat Related Companies NeoGenomics Earnings Results Niagen Bioscience Earnings Results Stoke Therapeutics Earnings Results Vir Biotechnology Earnings Results Day One Biopharmaceuticals Earnings Results AnaptysBio Earnings Results Dianthus Therapeutics Earnings Results GH Research Earnings Results Zenas BioPharma Earnings Results ArriVent BioPharma Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Post-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove It This page (OTCMKTS:BSEM) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.